You are here

The global eye drops and lubricants market generated $15,587 million in 2017 and is projected to reach $22,625 million by 2025, growing at a CAGR of 4.7% from 2018 to 2025

NEW YORK, Oct. 23, 2019 /PRNewswire/ --

Eye Drops and Lubricants Market by Type (Antibiotics, Hormones, Artificial Tears, and Others) and Application (Eye Diseases, Eye Care, and Others): Global Opportunity Analysis and Industry Forecast, 2018 - 2025

Download the full report:

The global eye drops and lubricants market generated $15,587 million in 2017 and is projected to reach $22,625 million by 2025, growing at a CAGR of 4.7% from 2018 to 2025.

Eye drops and lubricants are used to relieve people suffering from various eye problems, such as eye dryness, redness, infection (pink eye), allergies, itching, soreness, swelling, and others. Eye infections such as conjunctivitis and bacterial keratitis are chronic infections treated by using antibiotics therapy. Furthermore, eye and vision problems also occur due to imbalance in hormone levels, as hormones regulate important body functions and fluctuation in them can affect the eyes and vision. The discovery of advanced prospect molecules and novel combination therapies is expected to boost the growth of the eye drops and lubricants market in near future.

Rise in prevalence of ophthalmic disorders worldwide, change in the demographics across the globe, and focus on drug discovery and development for the treatment of eye disorder and diseases are the factors that drive the growth of the global eye drops and lubricants market. However, longer timelines required for the approval of eye drops and lubricants and risk of associated side effects hamper the market growth. On the contrary, surge in investment by manufacturers in the emerging economies and rise in initiatives to reduce the burden of glaucoma globally are anticipated to offer lucrative opportunities for market expansion.

The global eye drops market is segmented based on type, application, and region. By type, the market is categorized into antibiotics, hormones, artificial tears, and others. Based on application, the market is divided into eye diseases, eye care, and others. The eye diseases segment is further classified into dry eye, glaucoma, conjunctivitis, refractive errors, and others. Based on region, it is studied across North America, Europe, Asia-Pacific, and LAMEA.

- This report provides a detailed quantitative analysis of the current market trends and future estimations from 2018 to 2025, which assists to identify the prevailing market opportunities.
- An in-depth analysis of various regions is anticipated to provide a detailed understanding of the current trends to enable stakeholders to formulate region-specific plans.
- A comprehensive analysis of the factors that drive and restrain the growth of the global eye drops and lubricants market is provided.
- An extensive analysis of various regions provides insights that allow companies to strategically plan their business moves.

• By Type
o Antibiotics
o Hormones
o Artificial Tears
o Others
• By Application
o Eye Diseases
- Dry Eye
- Glaucoma
- Conjunctivitis
- Refractive Errors
- Others
o Eye Care
o Others
• By Region
o North America
• U.S.
o Europe
• UK
• Rest of Europe
o Asia-Pacific
• Rest of Asia-Pacific
Saudi Arabia
South Africa
• Rest of LAMEA
• Akorn Consumer Health (TheraTears)
• Allergan Plc
• Johnson & Johnson
• Novartis International AG (Alcon Inc.)
• Pfizer Inc.
• Prestige Consumer Healthcare, Inc.
• Sager Pharma Kft.
• ROHTO Pharmaceutical Co., Ltd.
• Similasan Corporation USA
• Valeant pharmaceuticals International, Inc. (Bausch & Lomb Incorporated)

The other players in the value chain include (profiles not included in the report):
• Jawa Pharmaceuticals Pvt. Ltd.
• Maya Biotech
• Neiss Labs Ltd.
• Hanuchem Laboratories
• Oculent Healthcare

Download the full report:

About Reportbuyer
Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers

For more information:
Sarah Smith
Research Advisor at
Tel: +1 (718) 213 4904

Cision View original content:

SOURCE ReportBuyer